NewsInvicta Diagnostic Limited Completes 51% Stake Acquisition in Vinchurkar Diagnostics Private LimitedInvicta Diagnostic Limited Completes 51% Stake Acquisition in Vinchurkar Diagnostics Private Limited
Invicta Diagnostic Limited completed the acquisition of a 51% stake in Vinchurkar Diagnostics Private Limited on May 8, 2026, with shares credited to its demat account. The transaction was approved across Board Meetings held on January 5, March 25, and April 11, 2026, and disclosed under Regulation 30 of the SEBI (LODR) Regulations, 2015. All required regulatory details had been previously submitted to the National Stock Exchange of India Limited. The disclosure was authorised by Chairman and Non-Executive Director Sanket Vinod Jain from Mumbai.
*this image is generated using AI for illustrative purposes only.
Invicta Diagnostic Limited has formally completed the acquisition of a 51% stake in Vinchurkar Diagnostics Private Limited, with the transaction concluded on May 8, 2026. The company confirmed that the shares have been credited to its demat account, marking the formal completion of this acquisition.
Acquisition Details
The acquisition was disclosed pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The key details of the transaction are summarised below:
| Parameter: | Details |
|---|---|
| Target Company: | Vinchurkar Diagnostics Private Limited |
| Stake Acquired: | 51% |
| Completion Date: | May 8, 2026 |
| Regulatory Framework: | Regulation 30, SEBI (LODR) Regulations, 2015 |
| Share Credit Status: | Credited to demat account |
Board Approvals and Regulatory Background
The acquisition follows a series of Board Meetings held on the following dates, during which the transaction was deliberated and approved:
- January 5, 2026
- March 25, 2026
- April 11, 2026
The company noted that all requisite details as required under Regulation 30, read with applicable SEBI Circulars, had already been submitted to the stock exchange through previous intimations and outcomes.
Disclosure and Authorisation
The disclosure was made by Sanket Vinod Jain, Chairman and Non-Executive Director of Invicta Diagnostic Limited (DIN: 08299039), from Mumbai, on May 8, 2026. The communication was addressed to the National Stock Exchange of India Limited and requested the exchange to take the update on record.
Historical Stock Returns for Invicta Diagnostic
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | -9.56% | +22.03% | -6.62% | -6.62% | -6.62% |
How does Invicta Diagnostic plan to integrate Vinchurkar Diagnostics' operations, and what synergies are expected to materialize in the next 12-24 months?
Will Invicta Diagnostic pursue acquisition of the remaining 49% stake in Vinchurkar Diagnostics, and what is the timeline for potential full consolidation?
How will this acquisition impact Invicta Diagnostic's revenue and EBITDA margins in the upcoming quarterly results?
17
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
